Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori—a randomized, controlled trial
Abstract:A 1-week course of clarithromycin and metronidazole in combination with a proton pump inhibitor is SUMMARY Background: One-week low-dose triple therapy is currently considered the gold standard regimen for treatment of Helicobacter pylori infection. However, the mechanisms involved in the synergy between antibiotics and proton pump inhibitors are controversial. Aims: To test the hypothesis that acid suppression represents the crucial mechanism by which the antibacterial activity of antibiotics can be enhanced,… Show more
“…Clarithromycin, nitroimidazole and a gastric acid inhibitor The most commonly tested regimen in our analysis treated 3128 subjects with clarithromycin, a nitroimidazole and a gastric acid inhibitor (CNG; Table 1). CNG treatment arms came from studies conducted in North America (two studies, 11 arms), South America (one study, two arms), Europe (21 studies, 58 arms), Asia (nine studies, 24 arms) and Australia (one study, four arms) 22, 31, 53, 54, 57, 60–64, 67–90 . The duration of CNG treatment ranged from 5 to 14 days.…”
“…Clarithromycin, nitroimidazole and a gastric acid inhibitor The most commonly tested regimen in our analysis treated 3128 subjects with clarithromycin, a nitroimidazole and a gastric acid inhibitor (CNG; Table 1). CNG treatment arms came from studies conducted in North America (two studies, 11 arms), South America (one study, two arms), Europe (21 studies, 58 arms), Asia (nine studies, 24 arms) and Australia (one study, four arms) 22, 31, 53, 54, 57, 60–64, 67–90 . The duration of CNG treatment ranged from 5 to 14 days.…”
“…Some data have been published showing that good H. pylori eradication results can be achieved using H 2 receptor antagonist [9,10,12,28], but there are only a few reports in which proton pump inhibitor and H 2 receptor antagonist were compared in two study arms with the same selection of antibiotics [10–12,28]. A recent randomized, controlled trial showed that famotidine and omeprazole, combined with clarithromycin and metronidazole, were equivalent for cure of H. pylori infection [10]. In contrast, other data showed that ranitidine, when used together with amoxicillin and metronidazole, was less effective than omeprazole [12].…”
The lafutidine-clarithromycin-amoxicillin therapy yielded satisfactory results for eradicating H. pylori, which was comparable with those of the lansoprazole-based regimen with the same drug combination.
“…For example, some randomized controlled studies showed the same eradication rates between PPIbased and H2RA-based 1-week triple therapies [65,66]. Meta-analytic studies have shown somewhat lower eradication rates in H2RA-based triple therapies than PPI-based triple therapies [33,67].…”
Section: (1) Ppis and H2ras In Combination Therapiesmentioning
The approach to the patient with suspected H. pylori infection consists of an adequate indication to test for the presence of the infection, choice of an appropriate antimicrobial regimen, and education about its use and side effects, followed by post-therapy testing to confirm cure. We review the drugs and regimens for H. pylori eradication and present a strategy for treating the infection. The major factor in choosing an antibiotic regimen is the pattern of antibiotic resistance in the community. Triple therapy with a proton pump inhibitor (PPI) or ranitidine bismuth citrate (RBC) and two antimicrobials is recommended as the first choice regimen. In regions where metronidazole and clarithromycin resistance are common, initial therapy with quadruple therapy consisting of bismuth, metronidazole, tetracycline, and a PPI is recommended. In general, higher doses and longer durations are associated with better outcomes. For this reason we recommend that the minimum duration of 10 days and we prefer 14 days. The actual choice of the antimicrobial combination will also be influenced by the drugs approved by the local regulatory bodies. Side effects, eradication failure and current as well as future designs of eradication therapies are also discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.